Skip to content
PubMed This is a summary of 41 peer-reviewed journal articles Updated
Endocrinology · Deficiency in anterior pituitary function–variable immunodeficiency syndrome

DAVID syndrome (Deficiency in anterior pituitary function-variable immunodeficiency syndrome): A Patient Guide

At a Glance

DAVID syndrome is a rare NFKB2-related condition that can cause low ACTH and cortisol, low antibody levels, and recurrent infections. Hydrocortisone, immunoglobulin therapy, and coordinated specialist care can help patients stay well and active.

DAVID syndrome is an exceptionally rare genetic condition that bridges two systems in the body that typically operate independently: the immune system and the endocrine (hormone) system. Its name is an acronym for Deficiency in Anterior pituitary function–Variable ImmunoDeficiency, reflecting the two primary challenges individuals with this condition face.

At its core, the syndrome is caused by a mutation in a gene called NFKB2, which serves as a critical biological instruction manual for both the development of the pituitary gland and the maturation of immune cells [1][2]. Because this single gene helps govern such diverse functions, a mutation can lead to a seemingly disconnected series of health issues that can take years to fully emerge.

The first major feature of DAVID syndrome involves the pituitary gland, a regulator located at the base of the brain. Specifically, the condition often leads to a deficiency in ACTH, a hormone that signals the adrenal glands to produce cortisol. Cortisol is essential for life, helping the body manage stress, maintain blood sugar, and regulate energy. Without enough of it, a person can experience central adrenal insufficiency. This requires careful daily management and emergency preparedness to ensure the body has the “stress hormone” it needs during times of illness or injury [3][4].

The second hallmark is hypogammaglobulinemia, a condition where the immune system struggles to produce enough antibodies to fight off infections. This typically results in frequent, recurrent infections of the sinuses and lungs. Interestingly, these immune issues and the hormone deficiencies often do not appear at the same time; many individuals struggle with infections for years before the signs of hormone loss become apparent. This staggered timeline is one reason why getting a clear diagnosis can be a long and complex journey for many families [1][5].

Despite the rarity of the syndrome itself, there is a strong foundation for hope and stability. The individual components—the hormone deficiency and the lack of antibodies—are well-understood by medical specialists. Standard treatments like hydrocortisone to replace missing cortisol and immunoglobulin therapy to provide missing antibodies are widely used. While care must be highly individualized, by working with a coordinated team of specialists to manage these two pillars of health, the condition is generally manageable, allowing patients to thrive, stay active, and lead fulfilling lives [3][6].

Common questions in this guide

What causes DAVID syndrome?
DAVID syndrome is caused by a mutation in the NFKB2 gene. This gene helps support pituitary function and the development of immune cells, so a mutation can lead to both low hormone production and reduced antibody production.
What health problems can DAVID syndrome cause?
DAVID syndrome can cause central adrenal insufficiency when the pituitary does not make enough ACTH to support cortisol production. It can also cause low antibody levels, leading to frequent or recurrent infections of the sinuses and lungs. These problems may appear at different times.
How is DAVID syndrome treated?
Hydrocortisone replaces the cortisol the body is not making adequately and requires planning for illness or injury. Immunoglobulin therapy can provide antibodies that help protect against infections. Treatment is individualized and coordinated by hormone and immune specialists.
Can someone with DAVID syndrome lead an active life?
DAVID syndrome is generally manageable when hormone deficiency and immune problems are monitored and treated. With individualized care, emergency planning, and coordinated specialists, patients may stay active and lead fulfilling lives.
Should relatives be tested for the NFKB2 mutation?
Because DAVID syndrome involves an NFKB2 mutation, a medical genetics professional can explain whether testing relatives is appropriate. The decision depends on the specific genetic finding and the family’s medical history.
How should we prepare for illness or injury with DAVID syndrome?
People with central adrenal insufficiency need a daily plan for replacing cortisol and an emergency plan for times of illness or injury. An endocrinology team can explain how to recognize urgent situations and what steps to take.

Get notified when new evidence is published on Deficiency in anterior pituitary function-variable immunodeficiency syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports.

    Mac TT, Castinetti F, Bar C, et al.

    Journal of neuroendocrinology 2023; (35(6)):e13287 doi:10.1111/jne.13287.

    PMID: 37322808
  2. 2

    Modeling corticotroph deficiency with pituitary organoids supports the functional role of NFKB2 in human pituitary differentiation.

    Mac TT, Fauquier T, Jullien N, et al.

    eLife 2024; (12()).

    PMID: 39607428
  3. 3

    Symptomatic hypoglycemia in a child with common variable immunodeficiency: Deficient anterior pituitary with variable immune deficiency (DAVID) syndrome.

    Nogueira M, Pinheiro M, Maia R, et al.

    Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2020; (29(3)):111-113 doi:10.1297/cpe.29.111.

    PMID: 32694887
  4. 4

    A Case Report of Hypoglycemia and Hypogammaglobulinemia: DAVID Syndrome in a Patient With a Novel NFKB2 Mutation.

    Lal RA, Bachrach LK, Hoffman AR, et al.

    The Journal of clinical endocrinology and metabolism 2017; (102(7)):2127-2130 doi:10.1210/jc.2017-00341.

    PMID: 28472507
  5. 5

    Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2.

    Klemann C, Camacho-Ordonez N, Yang L, et al.

    Frontiers in immunology 2019; (10()):297 doi:10.3389/fimmu.2019.00297.

    PMID: 30941118
  6. 6

    Emergency and perioperative management of adrenal insufficiency in children and young people: British Society for Paediatric Endocrinology and Diabetes consensus guidance.

    Mushtaq T, Ali SR, Boulos N, et al.

    Archives of disease in childhood 2023; (108(11)):871-878 doi:10.1136/archdischild-2022-325156.

    PMID: 37045585

This page is for informational purposes only and does not constitute medical advice about DAVID syndrome. Your endocrinology, immunology, and genetics specialists can interpret your situation and guide treatment.